← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 15, 2020Last known activity
Dec 31, 2024
Timeline
2010s
- Dec 9, 2015
Keros Therapeutics— Founded
Drugs by trial phase (4 distinct, 5 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT06499285Lead sponsorPhase 3Dec 31, 2024
- NCT05927012Lead sponsorPhase 2Nov 30, 2023
- NCT05975905Lead sponsorPhase 2Oct 17, 2023
- NCT05037760Lead sponsorPhase 2Sep 10, 2021
- NCT04419649Lead sponsorPhase 2Sep 15, 2020
Details
- Founded
- Lexington, Massachusetts, US Dec 9, 2015
- Last known activity
- Dec 31, 2024